Member Login
  1. Stocks
    2. /
  2. Smith & Nephew plc (NYSE: SNN)
    3. /

NYSE:SNN (Smith & Nephew plc)

About SNN

Smith+Nephew is a portfolio medical technology company focused on the repair, regeneration and replacement of soft and hard tissue. We exist to restore people's bodies and their self-belief by using technology to take the limits off living. We call this purpose 'Life Unlimited'. Our 17,000 employees deliver this mission every day, making a difference to patients' lives through the excellence of our product portfolio, and the invention and application of new technologies across our three global business units of Orthopaedics, Sports Medicine & ENT and Advanced Wound Management.
Financial Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

Smith & Nephew plc (NYSE: SNN) Latest News

Investing Articles

Could It Be Time For A Takeover Of Smith & Nephew plc?

| Alessandro Pasetti

Smith & Nephew plc (LON:SN) bears the hallmarks of a take-private deal.

Read more »

Investing Articles

Smith & Nephew plc: Shining Bright In A Greying World

| The Motley Fool Staff

Smith & Nephew plc (LON:SN) can benefit from an ageing population.

Read more »

Company Comment

3 FTSE Shares Hitting New Highs: Smith & Nephew plc, Persimmon plc And London Stock Exchange Group plc

| Mark Stones

Smith & Nephew plc (LON: SN), Persimmon plc (LON: PSN) and London Stock Exchange Group plc (LON: LSE) see their…

Read more »

Company Comment

Profits Boosted At Smith & Nephew plc

| Mark Stones

Smith & Nephew plc (LON:SN) beats market expectations.

Read more »